Significant impact of chromosomal locus 1p13.3 on serum LDL cholesterol and on angiographically characterized coronary atherosclerosis

Atherosclerosis

Volumn 206, Issue 2, 2009, Pages 494-499

  Muendlein, Axel ^a,c   Geller Rhomberg, Simone ^a,c   Saely, Christoph H ^a,b,c   Winder, Thomas ^a,b,c   Sonderegger, Gudrun ^a   Rein, Philipp ^a,b,c   Beer, Stefan ^a,b,c   Vonbank, Alexander ^a,b,c   Drexel, Heinz ^a,b,c,d  

^a Vorarlberg Institute for Vascular Investigation   (Austria)

^b ACADEMIC TEACHING HOSPITAL FELDKIRCH   (Austria)

^c Private University in the Principality of Liechtenstein   (Liechtenstein)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Coronary angiography; Coronary artery disease; LDL cholesterol; Single nucleotide polymorphism

Indexed keywords

ANTIDIABETIC AGENT; FIBRIC ACID DERIVATIVE; GENOMIC DNA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 1P; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CHOLESTEROL, LDL; CHROMOSOMES, HUMAN, PAIR 1; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC LOCI; HUMANS; MALE; MIDDLE AGED; RISK;

EID: 70349499340     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.02.040     Document Type: Article

References (27)

1. Kannel W.B., Dawber T.R., Kagan A., et al. Factors of risk in the development of coronary heart disease-six year follow-up experience, The Framingham Study. Ann Intern Med 55 (1961) 33-50
2. Heuch I., Namboodiri K.K., Green P.P., et al. A multivariate analysis of familial associations of lipoprotein levels in the Lipid Research Clinics Collaborative Family Study. I. Familial correlation and regression analyses. Genet Epidemiol 2 (1985) 283-300
3. Lusis A.J., Fogelman A.M., and Fonarow G.C. Genetic basis of atherosclerosis: part I: new genes and pathways. Circulation 110 (2004) 1868-1873
4. Kullo I.J., and Ding K. Mechanisms of disease: the genetic basis of coronary heart disease. Nat Clin Pract Cardiovasc Med 4 (2007) 558-569
5. Winkelmann B.R., and Hager J. Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidence. Pharmacogenomics 1 (2000) 73-94
6. Fan J.B., Chee M.S., and Gunderson K.L. Highly parallel genomic assays. Nat Rev Genet 7 (2006) 632-644
7. Sandhu M.S., Waterworth D.M., Debenham S.L., et al. LDL-cholesterol concentrations: a genome-wide association study. Lancet 371 (2008) 483-491
8. Kathiresan S., Melander O., Guiducci C., et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40 (2008) 189-197
9. Willer C.J., Sanna S., Jackson A.U., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40 (2008) 161-169
10. Samani N.J., Erdmann J., Hall A.S., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 357 (2007) 443-453
11. Fuster V., Badimon L., Badimon J.J., and Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 326 (1992) 242-250
12. Fuster V., Badimon L., Badimon J.J., and Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 326 (1992) 310-318
13. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
14. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72.
15. Drexel H., Amann F.W., Rentsch K., et al. Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am J Cardiol 70 (1992) 436-440
16. Drexel H., Amann F.W., Beran J., et al. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation 90 (1994) 2230-2235
17. Gaunt T.R., Rodriguez S., and Day I.N. Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool 'CubeX'. BMC Bioinformatics 8 (2007) 428
18. Xie X., and Ott J. Testing linkage disequilibrium between a disease gene and marker loci. Am J Hum Genet 53 (1993) 1107 [abstract]
19. Gauderman W.J. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155 (2002) 478-484
20. Simeoni E., Winkelmann B.R., Hoffmann M.M., et al. Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J 25 (2004) 1438-1446
21. Marroquin O.C., Kip K.E., Kelley D.E., et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation 109 (2004) 714-721
22. Nissen S.E. Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. Am J Cardiol 96 (2005) 61F-68F
23. Schadt E.E., Molony C., Chudin E., et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol 6 (2008) e107
24. Vincent J.B., Skaug J., and Scherer S.W. The human homologue of flamingo, EGFL2, encodes a brain-expressed large cadherin-like protein with epidermal growth factor-like domains, and maps to chromosome 1p13.3-p21.1. DNA Res 7 (2000) 233-235
25. Hsieh P.C., Chang J.C., Sun W.T., et al. p53 downstream target DDA3 is a novel microtubule-associated protein that interacts with end-binding protein EB3 and activates beta-catenin pathway. Oncogene 26 (2007) 4928-4940
26. Nielsen M.S., Jacobsen C., Olivecrona G., et al. Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem 274 (1999) 8832-8836
27. Samani N.J., Braund P.S., Erdmann J., et al. The novel genetic variant predisposing to coronary artery disease in the region of the PSRC1 and CELSR2 genes on chromosome 1 associates with serum cholesterol. J Mol Med 86 (2008) 1233-1241